Tagged with BfArM

Implementation of the Medical Research Act: An Enabling Architecture for Clinical Trial Research in Germany

Germany Implementation of the Medical Research Act: An Enabling Architecture for Clinical Trial Research in Germany

Germany Germany’s Medical Research Act is almost two years old. Writing in the June/July 2026 edition of DIA Global Forum, Thomas Sudhop, Claudia Riedel and Karl Broich of the Federal Institute for Drugs and Medical Devices (BfArM) outline how the Act attempts to revitalise clinical research in Germany, balancing faster procedures…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here